This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research Article
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Damage to the spinal cord is the most serious complication of spinal injury. The method to reduce fibrogenesis after spinal cord injury, to facilitate repair, is an ongoing hurdle despite advancements in research. Non-coding RNA plays an important role in the progression of many diseases, but the study of its role in the progression of spinal fibrosis is still emerging. Here, we investigated the function of circular RNAs, specifically CDR1as, in spinal fibrosis and characterized its molecular mechanism and pathophysiology. The presence of CDR1as in the spinal cord was verified by sequencing and polymerase chain reaction assays. Further, gene and protein expression of miR-7a-5p and TGF-βR2 were measured to evaluate their predicted interactions. The combination miR-7a-5p/TGF-βR2 was predicted by bioinformatics and validated using a luciferase reporter assay. The regulatory effects and activation pathways of miR-7a-5p and CDR1as on spinal fibrosis were subsequently verified by Western blot. miR-7a-5p inhibitor and siCDR1as were transfected and inhibited the effect of siCDR1as. These results indicate that CDR1as/miR-7a-5p/TGF-βR2 interactions may exert important functions and suggest potential therapeutic targets for treating spinal fibrotic diseases.
Keywords
spinal cord injury, fibrosis, CircRNA, CDR1as, miR-7
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
This is a list of supplementary files associated with this preprint. Click to download.
- figureS1.pdf
Figure S1. CircRNA/miRNA/mRNA network.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 15 Mar, 2021
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Applied Biochemistry
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research Article
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 15 Mar, 2021
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Applied Biochemistry
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Damage to the spinal cord is the most serious complication of spinal injury. The method to reduce fibrogenesis after spinal cord injury, to facilitate repair, is an ongoing hurdle despite advancements in research. Non-coding RNA plays an important role in the progression of many diseases, but the study of its role in the progression of spinal fibrosis is still emerging. Here, we investigated the function of circular RNAs, specifically CDR1as, in spinal fibrosis and characterized its molecular mechanism and pathophysiology. The presence of CDR1as in the spinal cord was verified by sequencing and polymerase chain reaction assays. Further, gene and protein expression of miR-7a-5p and TGF-βR2 were measured to evaluate their predicted interactions. The combination miR-7a-5p/TGF-βR2 was predicted by bioinformatics and validated using a luciferase reporter assay. The regulatory effects and activation pathways of miR-7a-5p and CDR1as on spinal fibrosis were subsequently verified by Western blot. miR-7a-5p inhibitor and siCDR1as were transfected and inhibited the effect of siCDR1as. These results indicate that CDR1as/miR-7a-5p/TGF-βR2 interactions may exert important functions and suggest potential therapeutic targets for treating spinal fibrotic diseases.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
This is a list of supplementary files associated with this preprint. Click to download.
- figureS1.pdf
Figure S1. CircRNA/miRNA/mRNA network.
Loading...